Royalty Pharma Quote - RPRX

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

32.0084

Bid

31.74

Ask

33.00

Volume

4,822,379

32.285 Day's Range 32.89

24.05 52 Week Range 32.85

Market Cap

18.859B

Previous Close

32.46

Open

32.46

Last Trade

Last Trade Time

Financial Volume

US$ 157,077,504

VWAP

32.5726

Average Volume (3m)

3,635,988

Shares Outstanding

589,182,783

Dividend Yield

2.75%

PE Ratio

16.80

Earnings Per Share (EPS)

1.93

Revenue

2.35B

Net Profit

1.13B

Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry's therapies, which includes royalti... Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company assembles a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry's therapies, which includes royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Johnson & Johnson's Tremfya, Gilead's Trodelvy, Merck's Januvia, Novartis' Promacta, Vertex's Kalydeco, Orkambi, Symdeko and Trikafta, and ten development-stage product candidates. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.royaltypharma.com

Headquarters

Bristol, Gbr

Founded

Royalty Pharma PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RPRX. The last closing price for Royalty Pharma was US$32.46. Over the last year, Royalty Pharma shares have traded in a share price range of US$ 24.05 to US$ 32.85.

Royalty Pharma currently has 589,182,783 shares outstanding. The market capitalization of Royalty Pharma is US$19.12 billion. Royalty Pharma has a price to earnings ratio (PE ratio) of 16.80.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.5284	1.67852604828	31.48	32.85	31.3	4408601	32.1424293	CS
4	1.2884	4.19401041667	30.72	32.85	29.725	4133199	31.58425232	CS
12	5.6284	21.3358605004	26.38	32.85	24.05	3635988	28.5363174	CS
26	5.1984	19.3897799329	26.81	32.85	24.05	2914846	27.99846114	CS
52	2.7384	9.3556542535	29.27	32.85	24.05	2853255	28.12319794	CS
156	-7.4616	-18.9044844185	39.47	44.75	24.05	2314521	32.37679318	CS
260	-13.8916	-30.2649237473	45.9	57.5	24.05	2265908	35.97504329	CS

RPRX - Frequently Asked Questions (FAQ)

What is the current Royalty Pharma share price?

The current share price of Royalty Pharma is US$ 32.0084

How many Royalty Pharma shares are in issue?

Royalty Pharma has 589,182,783 shares in issue

What is the market cap of Royalty Pharma?

The market capitalisation of Royalty Pharma is USD 19.12B

What is the 1 year trading range for Royalty Pharma share price?

Royalty Pharma has traded in the range of US$ 24.05 to US$ 32.85 during the past year

What is the PE ratio of Royalty Pharma?

The price to earnings ratio of Royalty Pharma is 16.8

What is the cash to sales ratio of Royalty Pharma?

The cash to sales ratio of Royalty Pharma is 8.1

What is the reporting currency for Royalty Pharma?

Royalty Pharma reports financial results in USD

What is the latest annual turnover for Royalty Pharma?

The latest annual turnover of Royalty Pharma is USD 2.35B

What is the latest annual profit for Royalty Pharma?

The latest annual profit of Royalty Pharma is USD 1.13B

What is the registered address of Royalty Pharma?

The registered address for Royalty Pharma is THE PAVILIONS BRIDGWATER ROAD, BRISTOL, BS13 8AE

What is the Royalty Pharma website address?

The website address for Royalty Pharma is www.royaltypharma.com

Which industry sector does Royalty Pharma operate in?

Royalty Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
JTAIJet AI Inc	US$ 6.02 (133.33%)	104.48M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	254.39M
WRDWeRide Inc	US$ 31.4877 (83.39%)	21.07M
INLFINLIF Limited	US$ 16.27 (80.58%)	7.68M
MBRXMoleculin Biotech Inc	US$ 2.1201 (66.94%)	136.66M
BLACBellevue Life Sciences Acquisition Corporation	US$ 3.08 (-56.31%)	430.77k
BLACUBellevue Life Sciences Acquisition Corporation	US$ 3.36 (-52.68%)	5.21k
CSAICloudastructure Inc	US$ 19.0001 (-49.58%)	1.03M
NEXNNexxen International Ltd	US$ 10.30 (-49.16%)	164.82k
BSLKBolt Projects Holdings Inc	US$ 0.6626 (-46.13%)	13.4M
CNSPCNS Pharmaceuticals Inc	US$ 0.1415 (31.26%)	489.28M
MGOLMGO Global Inc	US$ 0.7176 (-15.08%)	417.31M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	254.39M
INTCIntel Corporation	US$ 23.60 (-2.20%)	230.26M
NVDANVIDIA Corporation	US$ 138.85 (2.63%)	194.99M